TAMPERE, Finland--(BUSINESS WIRE)--Combinostics, provider of artificial intelligence (AI) technology to help radiologists, clinicians, and researchers make confident, evidence-based decisions for ...
The Dementia Differential Analysis report visualizes comparisons of patient MRI biomarkers with data from patients with various types of dementia or normal cognition. TAMPERE, Finland--(BUSINESS WIRE) ...
NAPLES, Fla., Nov. 15, 2022 (GLOBE NEWSWIRE) -- Fountain Health is proud to officially announce 100 percent coverage of Combinostics cMRI™ and cDSI™ — the industry-leading AI-enabled neurological ...
SAN FRANCISCO, Nov. 26, 2021 (GLOBE NEWSWIRE) -- Arterys, the world's leading vendor neutral AI platform, today announced its partnership with Combinostics to make their AI imaging solution, cNeuro® ...
Dr. Erik Post and Dr. Hans-Peter Huber join as Group Chief Financial Officer and Vice President of European Sales, respectively. TAMPERE, Finland--(BUSINESS WIRE)--#aihealthcare--Combinostics, the ...
CAMBRIDGE, Mass., April 27, 2023 /PRNewswire/ -- The Eureka Clinical AI platform, from ConcertAI's TeraRecon, now provides clinicians with the state-of-the-art artificial intelligence and deep ...
Tampere, Finland-based startup Combinostics, maker of data-driven clinical assessment software, has secured €3.9m in a Series A funding round led by Industrifonden and NordicNinja VC, it was announced ...
Improvements and new applications within suite of products support clinicians with objective, quantifiable insights for their patients with neurological disorders Combinostics, provider of artificial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback